SCHEMBL7924311

SCHEMBL7924311

O=C(O)C(=O)CC(=O)c1cccn1Cc1ccccc1Cl

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.66
MAP3K14 Q99558 1/20 0.66
PTGER3 P43115 11/20 0.50
FEN1 P39748 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ERCC5 P28715 2/20 0.50
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 2/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7191689 0.84 CNR2 (0.53) LMNAMAP3K14FEN1SMN1; SMN2ERCC5
SCHEMBL7195496 0.84 PTPN1 (0.50) LMNAMAP3K14PTGER3FEN1ERCC5
SCHEMBL7188720 0.84 ERCC5 (0.50) LMNAMAP3K14PTGER3FEN1ERCC5
SCHEMBL7195321 0.84 HDAC3 (0.47) LMNAMAP3K14PTGER3FEN1ERCC5
SCHEMBL31466359 0.83 LMNA (0.77) LMNAMAP3K14PTGER3SMN1; SMN2RAB9A
SCHEMBL7185737 0.83 LMNA (0.44) LMNAMAP3K14FEN1ERCC5ALDH1A1
SCHEMBL7186087 0.82 CNR2 (0.45) LMNAMAP3K14FEN1ERCC5RAB9A
SCHEMBL7186933 0.81 FEN1 (0.51) FEN1ERCC5RAB9ANPC1KDM4E
SCHEMBL7190690 0.80 CNR2 (0.54) FEN1ERCC5KDM4E
SCHEMBL7195627 0.79 PTPN1 (0.44) LMNAMAP3K14PTGER3FEN1ERCC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US claimed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US disclosed